Últimas notícias Butantan Institute

Chegada de 59.800 doses da vacina CoronaVac (17.03.2021)
Foto: Breno Esaki/Agência Saúde DF
Health

Butantan study shows higher efficiency of CoronaVac

Study found 99% of vaccinated people in Serrana seroconverted.The indicator was higher than the results from the clinical trials from phases one and two of CoronaVac, showing seroconversion at around 97 and 98 percent, respectively, depending on the dose.

Chegada de 59.800 doses da vacina CoronaVac (17.03.2021)
Foto: Breno Esaki/Agência Saúde DF
Fachada,Instituto Butantan
Health

Butantan Institute starts producing its vaccine against COVID-19

ButanVac will be produced at the Butantan factory where flu vaccines are made—a production that has already come to an end this year. ButanVac will be fully manufactured in São Paulo, with no imported supplies necessary.

Divulgada sequência genética de vírus dois dias depois de surgir o primeiro caso no Brasil. Artigos científicos são publicados com rapidez em todo o mundo (foto: Instituto Adolfo Lutz)
Health

Three new coronavirus variants confirmed in São Paulo

They are variant B.1.318, found in Switzerland and the UK; South African B.1.351; and N9, a mutation of Amazon variant P1, observed in a number of Brazilian states.

Caixas com vacinas experimentais contra Covid-19 da Sinovac em Pequim. coronavac
Health

Studies show CoronaVac efficient against three coronavirus variants

It is efficient against the British B.1.1.7, the South African B.1.351, and Brazil’s B.1.1.28, of which are derived variants P.1, from Manaus, and P.2, from Rio de Janeiro.